NDT Advance Access originally published online on September 12, 2006
Nephrology Dialysis Transplantation 2006 21(12):3371-3373; doi:10.1093/ndt/gfl480
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Complement-ary matching: a definite maybe*
Department of Nephrology and Center for Cardiovascular Research, Charité University Medicine Berlin, Berlin, Germany
Correspondence and offprint requests to: Dr Duska Dragun, Department of Nephrology and Critical Care Medicine, Charité CVK, Augustenburger, Platz 1, 133353 Berlin, Germany. Email: duska.dragun@charite.de
Keywords: complement; C3; C3F/S allotypes; kidney transplantation
| The first 10% of the full text of this article appears below. |
The mammalian complement system has evolved as an important bridge between the innate and adaptive immune system, with responsibility for host defense against pyogenic bacteria, disposal of immune complexes and the products of inflammatory injury [1]. Three different pathways (Figure 1, panel A) lead to activation of the complement system [2]. First discovered was the classical, antigen-antibody binding-initiated pathway. Of no lesser importance is the mannose-binding lectin-mediated pathway. The evolutionarily oldest complement defense is the alternative pathway [1]. The central complement protein C3 represents the point of convergence for all three recognized activation pathways and plays a decisive role in a variety of physiological and pathological processes pivotal to the complement cascade.